292 related articles for article (PubMed ID: 21829172)
1. Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet?
Naujok O; Burns C; Jones PM; Lenzen S
Mol Ther; 2011 Oct; 19(10):1759-68. PubMed ID: 21829172
[TBL] [Abstract][Full Text] [Related]
2. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
3. Islet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo.
Kim Y; Kim H; Ko UH; Oh Y; Lim A; Sohn JW; Shin JH; Kim H; Han YM
Sci Rep; 2016 Oct; 6():35145. PubMed ID: 27731367
[TBL] [Abstract][Full Text] [Related]
4. High oxygen condition facilitates the differentiation of mouse and human pluripotent stem cells into pancreatic progenitors and insulin-producing cells.
Hakim F; Kaitsuka T; Raeed JM; Wei FY; Shiraki N; Akagi T; Yokota T; Kume S; Tomizawa K
J Biol Chem; 2014 Apr; 289(14):9623-38. PubMed ID: 24554704
[TBL] [Abstract][Full Text] [Related]
5. microRNA-690 regulates induced pluripotent stem cells (iPSCs) differentiation into insulin-producing cells by targeting Sox9.
Xu Y; Huang Y; Guo Y; Xiong Y; Zhu S; Xu L; Lu J; Li X; Wan J; Lu Y; Wang Z
Stem Cell Res Ther; 2019 Feb; 10(1):59. PubMed ID: 30767782
[TBL] [Abstract][Full Text] [Related]
6. Scalable production of pancreatic islet progenitors for diabetes cell therapies.
Lock LT; Tzanakakis ES
Med J Malaysia; 2008 Jul; 63 Suppl A():5-6. PubMed ID: 19024957
[TBL] [Abstract][Full Text] [Related]
7. Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells.
Kondo Y; Toyoda T; Ito R; Funato M; Hosokawa Y; Matsui S; Sudo T; Nakamura M; Okada C; Zhuang X; Watanabe A; Ohta A; Inagaki N; Osafune K
Diabetologia; 2017 Aug; 60(8):1454-1466. PubMed ID: 28534195
[TBL] [Abstract][Full Text] [Related]
8. Examining the therapeutic potential of various stem cell sources for differentiation into insulin-producing cells to treat diabetes.
Pan G; Mu Y; Hou L; Liu J
Ann Endocrinol (Paris); 2019 Feb; 80(1):47-53. PubMed ID: 30041820
[TBL] [Abstract][Full Text] [Related]
9. Generation of pancreatic islet cells from human embryonic stem cells.
Zhang D; Jiang W; Shi Y; Deng H
Sci China C Life Sci; 2009 Jul; 52(7):615-21. PubMed ID: 19641866
[TBL] [Abstract][Full Text] [Related]
10. A comparison of protocols used to generate insulin-producing cell clusters from mouse embryonic stem cells.
Boyd AS; Wu DC; Higashi Y; Wood KJ
Stem Cells; 2008 May; 26(5):1128-37. PubMed ID: 18323410
[TBL] [Abstract][Full Text] [Related]
11. Stem cells in diabetes: what has been achieved.
Bonner-Weir S
Horm Res; 2003; 60 Suppl 3():10. PubMed ID: 14671389
[TBL] [Abstract][Full Text] [Related]
12. Stem cell applications in diabetes.
Noguchi H
J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
[TBL] [Abstract][Full Text] [Related]
13. Generation of new islets from stem cells.
Roche E; Soria B
Cell Biochem Biophys; 2004; 40(3 Suppl):113-24. PubMed ID: 15289648
[TBL] [Abstract][Full Text] [Related]
14. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
[TBL] [Abstract][Full Text] [Related]
15. Dynamic expression of microRNAs during the differentiation of human embryonic stem cells into insulin-producing cells.
Wei R; Yang J; Liu GQ; Gao MJ; Hou WF; Zhang L; Gao HW; Liu Y; Chen GA; Hong TP
Gene; 2013 Apr; 518(2):246-55. PubMed ID: 23370336
[TBL] [Abstract][Full Text] [Related]
16. Insulin-producing cells.
Schroeder IS; Kania G; Blyszczuk P; Wobus AM
Methods Enzymol; 2006; 418():315-33. PubMed ID: 17141044
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Pancreas Islet-Releasing Factors on the Direction of Embryonic Stem Cells Towards Pdx1 Expressing Cells.
Elham H; Mahmoud H
Appl Biochem Biotechnol; 2018 Oct; 186(2):371-383. PubMed ID: 29637395
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel beta-cell specific promoter system for the identification of insulin-producing cells in in vitro cell cultures.
Fukazawa T; Matsuoka J; Naomoto Y; Nakai T; Durbin ML; Kojima I; Lakey JR; Tanaka N
Exp Cell Res; 2006 Oct; 312(17):3404-12. PubMed ID: 16934249
[TBL] [Abstract][Full Text] [Related]
19. MAFA and T3 Drive Maturation of Both Fetal Human Islets and Insulin-Producing Cells Differentiated From hESC.
Aguayo-Mazzucato C; DiIenno A; Hollister-Lock J; Cahill C; Sharma A; Weir G; Colton C; Bonner-Weir S
J Clin Endocrinol Metab; 2015 Oct; 100(10):3651-9. PubMed ID: 26207953
[TBL] [Abstract][Full Text] [Related]
20. Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing beta-cell-like cells.
Brolén GK; Heins N; Edsbagge J; Semb H
Diabetes; 2005 Oct; 54(10):2867-74. PubMed ID: 16186387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
